John P. Roberts, MD, FACS

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
John P. Roberts, MD, FACS

Professor, Department of Surgery, and Chief, Division of Transplantation, UCSF

Phone: (415) 353-1888 (appts)
Box 0780, UCSF
San Francisco, CA 94143-0780

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned

Additional Websites


Education

Stanford University, Palo Alto, CA, BS, 1976, Biology
University of California, San Diego, CA, MD, 1980, Medicine
University of Washington, Seattle, Surgery Resident, 1980-83
Cornell University, New York, Research Fellow, 1983-85
University of Washington, Seattle, Surgery Resident, 1985-86
University of Minnesota, Minneapolis, Transplant Fellow, 1986-87


Professional Experience

  • 1988-1993
    University of California San Francisco, Assistant Professor
  • 1993-1997
    University of California San Francisco, Associate Professor
  • 1995-present
    California Pacific Medical Center, San Francisco, Surgical Director, Liver Transplant Department
  • 1997-present
    University of California San Francisco, Professor
  • 1999-present
    University of California San Francisco, Chief, Transplant Service

Honors & Awards

  • 1991
    Chief Resident Teaching Award, Department of Surgery, UCSF
  • 1992
    Chief Resident Teaching Award, Department of Surgery, UCSF

Selected Publications

  1. Axelrod DA, Vagefi PA, Roberts JP. The Evolution of Organ Allocation for Liver Transplantation: Tackling Geographic Disparity Through Broader Sharing. Ann Surg. 2015 Aug; 262(2):224-7.
    View on PubMed
  2. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
    View on PubMed
  3. Macdonald B, Sewell JL, Harper AM, Roberts JP, Yao FY. Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant. 2015 Mar 17.
    View on PubMed
  4. Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clin Transplant. 2015 Jan; 29(1):52-9.
    View on PubMed
  5. Roberts JP. Does center-specific reporting limit innovation. Liver Transpl. 2014 Nov; 20 Suppl 2:S42-4.
    View on PubMed
  6. Feng K, Gupta V, Terrazas E, Yeghiazarians Y, Ports T, Gregoratos G, Tavakol M, Roberts JP, Boyle A. Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization. Am J Cardiovasc Dis. 2014; 4(3):133-9.
    View on PubMed
  7. Yao FY, Hameed B, Mehta N, Roberts JP. Response to letter to the editors. Liver Transpl. 2014 Oct; 20(10):1285.
    View on PubMed
  8. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014 Aug; 20(8):945-51.
    View on PubMed
  9. Samoylova ML, Dodge JL, Yao FY, Roberts JP. Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2014 Aug; 20(8):937-44.
    View on PubMed
  10. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver Transpl. 2014 May; 20(5):627-8.
    View on PubMed
  11. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl. 2013 Dec; 19(12):1343-53.
    View on PubMed
  12. Perito ER, Rhee S, Roberts JP, Rosenthal P. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl. 2014 Jan; 20(1):89-99.
    View on PubMed
  13. Neidich E, Neidich AB, Axelrod DA, Roberts JP. Consumerist responses to scarcity of organs for transplant. Virtual Mentor. 2013 Nov; 15(11):966-72.
    View on PubMed
  14. Samoylova ML, Dodge JL, Vittinghoff E, Yao FY, Roberts JP. Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. Liver Transpl. 2013 Dec; 19(12):1318-23.
    View on PubMed
  15. Keedy AW, Breiman RS, Webb EM, Roberts JP, Coakley FV, Yeh BM. Determinants of second-order bile duct visualization at CT cholangiography in potential living liver donors. AJR Am J Roentgenol. 2013 May; 200(5):1028-33.
    View on PubMed
  16. Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl. 2013 May; 19(5):472-81.
    View on PubMed
  17. Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl. 2013 Apr; 19(4):457-61.
    View on PubMed
  18. Lai JC, Feng S, Vittinghoff E, Roberts JP. Offer patterns of nationally placed livers by donation service area. Liver Transpl. 2013 Apr; 19(4):404-10.
    View on PubMed
  19. Roberts JP. Impact of outcomes monitoring on innovation and risk in liver transplantation. Liver Transpl. 2012 Nov; 18 Suppl 2:S59-63.
    View on PubMed
  20. Rothbaum Perito E, Lau A, Rhee S, Roberts JP, Rosenthal P. Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review. Liver Transpl. 2012 Sep; 18(9):1009-28.
    View on PubMed

Go to UCSF Profiles, powered by CTSI